Terry Fox Research Institute
Overview
The Terry Fox Research Institute is a Canadian non-profit research organization that funds and manages collaborative cancer research teams and partnerships to accelerate the translation of scientific discoveries into clinical practice.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Nanogenix | Jul 2023 | Grant | Co-investor |
| Dinamik Therapies | Jul 2023 | Seed | Co-investor |
Key People
Jim Woodgett
President and Director of Research
Isabel Serrano
Managing Director, MOHCCN
Gordon Schwark
Chief Financial Officer
Jorge Ligason
Director of Finance
Michelle Honsberger
Director of Finance
Kelly Curwin
Chief Communications Officer
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Terry Fox Research Institute based?
Terry Fox Research Institute is headquartered in Vancouver, Canada.
When was Terry Fox Research Institute founded?
Terry Fox Research Institute was founded in 2007.
How many portfolio companies does Terry Fox Research Institute have?
Terry Fox Research Institute has 2 portfolio companies in Caplight's dataset.
What are some companies in Terry Fox Research Institute's portfolio?
Portfolio companies visible on Caplight include Nanogenix, Dinamik Therapies.
What was Terry Fox Research Institute's most recent investment shown here?
Terry Fox Research Institute's most recent investment in this portfolio sample was in Nanogenix in 2023.
What sectors does Terry Fox Research Institute focus on?
Terry Fox Research Institute focuses on Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Terry Fox Research Institute focus on?
Terry Fox Research Institute typically invests at the Early stage.